Compounds > 1-(5-isoquinolinesulfonyl)-2-methylpiperazine

1-(5-isoquinolinesulfonyl)-2-methylpiperazine and everolimus

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with everolimus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fang, Q; Gan, Z; Gu, T; Niu, K; Yu, Q; Zhang, Y	1

Other Studies

1 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and everolimus

Article	Year
Time-dependently slow-released multiple-drug eluting external sheath for efficient long-term inhibition of saphenous vein graft failure. Journal of controlled release : official journal of the Controlled Release Society, 2019, 01-10, Volume: 293 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Coronary Artery Bypass; Drug Delivery Systems; Everolimus; Graft Rejection; Immunosuppressive Agents; Rabbits; Saphenous Vein; Simvastatin	2019

Article

Year

Time-dependently slow-released multiple-drug eluting external sheath for efficient long-term inhibition of saphenous vein graft failure.

Journal of controlled release : official journal of the Controlled Release Society, 2019, 01-10, Volume: 293

Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Coronary Artery Bypass; Drug Delivery Systems; Everolimus; Graft Rejection; Immunosuppressive Agents; Rabbits; Saphenous Vein; Simvastatin

2019